Searched for
LANCET INDIA
Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...- Heatwaves in India could rise 400% by century-end, putting health and jobs at risk
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Nearly two-fifths of stillbirths missed if only late gestation counted: AnalysisNew data analysis shows stillbirth rates are higher than previously thought. Focusing only on late-gestation stillbirths misses almost 40 p...
- India rubbishes Lancet's claim of lack of accuracy, transparency in dataLancet, a prominent medical journal, questioned the accuracy and transparency of India's healthcare data, prompting officials to defend the...
- More than 1 billion people worldwide are obese: LancetObesity rates among children and adolescents worldwide increased four times from 1990 to 2022. Among adults, the obesity rate more than dou...
- British medical journal 'The Lancet' to come out in HindiMadhya Pradesh Medical Education Minister Vishwas Sarang said 'The Lancet Regional Health - Southeast Asia' - will be translated into Hindi...
- India could face third highest economic burden of COPD from 2020-50: Lancet StudyThe global death toll of COPD was found to have increased by 14.1 per cent between 2009 and 2019, an increase that the study attributed to ...
- View: The climate fight will be more effective if data is presented without sensationalism'Heat-related deaths in India are up 55% because of climate change' was a headline reported by various media outlets last week. While this ...
- India had the highest excess deaths related to Coronavirus, says Lancet in new reportThe new study provides the first peer-reviewed estimates of excess deaths due to the pandemic globally and for 191 countries and territorie...
- Bharat Biotech’s Covaxin has 77.8% efficacy rate, presents no safety concerns: Lancet studyCovaxin “induces a robust antibody response" two weeks after two doses are given, it said. “Covaxin’s Phase 3 efficacy results have been pe...
- Susceptibility to Covid high immediately after vaccinationSeveral cases of infections have been reported after taking Covid vaccinations across the country. The observation may explain some of that...
- An almost retracted study on hydroxychloroquine exposes perils of hasty trialsWHO last week stopped one arm of the Covid-19 Solidarity trial of HCQ, only to resume it again this week. Its decision to stop the trial wa...
- Rates of testing low in India: LancetLancet said that some reports suggest that the government's efforts to provide financial support and a measure of food security to ease the...
- Alarming gap between Lancet & NCRB suicide dataExperts mainly attribute the lower figures provided by NCRB to under-reporting and the fact that NCRB draws its data from First Information...
- Narendra Modi first Indian PM to prioritise universal health coverage: LancetRichard Horton, editor-in-chief of the 'The Lancet', said the prime minister has grasped the importance of health not only as a natural rig...
- Patna, Delhi among most polluted cities: ReportAir pollution is killing two people in India every minute, with the country’s environment turning more toxic by the day, says a new study p...
- India, China suffer heavily due to air pollution: StudyIndia and China suffer over $1.89 trillion annually in terms of the value of lives lost and ill health caused from air pollution, according...
- India, China suffer heavily due to air pollution: StudyIndia and China suffer over USD 1.89 trillion annually in terms of the value of lives lost and ill health caused from air pollution.
- India 'supressing' truth about NDM-I: LancetInternational health journal Lancet has slammed the government for "suppressing" truth about the presence of a drug-resistant bacteria in D...
Load More
